Cargando…

Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later

INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvaro, Domenico, Coluzzi, Flaminia, Gianni, Walter, Lugoboni, Fabio, Marinangeli, Franco, Massazza, Giuseppe, Pinto, Carmine, Varrassi, Giustino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098716/
https://www.ncbi.nlm.nih.gov/pubmed/35122615
http://dx.doi.org/10.1007/s40122-022-00354-4
_version_ 1784706440770879488
author Alvaro, Domenico
Coluzzi, Flaminia
Gianni, Walter
Lugoboni, Fabio
Marinangeli, Franco
Massazza, Giuseppe
Pinto, Carmine
Varrassi, Giustino
author_facet Alvaro, Domenico
Coluzzi, Flaminia
Gianni, Walter
Lugoboni, Fabio
Marinangeli, Franco
Massazza, Giuseppe
Pinto, Carmine
Varrassi, Giustino
author_sort Alvaro, Domenico
collection PubMed
description INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the need of standardization of diagnosis and treatment, and the urgency of further education. Herein, we submitted an updated version of the survey to the same cohort of experts to evaluate potential progress. METHODS: The online survey included 15 questions about OIC. Responses were analyzed descriptively and aggregated by physician specialty. RESULTS: A total of 190 physicians completed the survey. Most respondents (65%) did not feel adequately educated about OIC despite general consensus regarding interest in the topic and acknowledgement of OIC impact on patients’ QoL and adherence to opioid therapy. Overall, 55–77% of physicians regularly evaluated intestinal function or OIC symptoms in patients receiving opioid therapy, with one-third of respondents implementing it in the past year. Even though the most common method for assessment was still patient diary, the use of specific scales underwent a small but significant increase compared to the previous year, with major implementation in the use of Rome IV criteria. As regards first-line treatment, most respondents (49%) preferred macrogol prophylaxis followed by macrogol plus another laxative. For second-line treatment, we revealed a growth in the prescription of peripherally acting mu-opioid receptor antagonists (PAMORAs), with 46% of all the respondents having increased their use during the past year. CONCLUSIONS: Despite some limitations, our study demonstrated a slow but important step closer to standardization of diagnosis and treatment of OIC. Further educational and training efforts should be put in place to favor best evidence-based clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00354-4.
format Online
Article
Text
id pubmed-9098716
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-90987162022-05-14 Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later Alvaro, Domenico Coluzzi, Flaminia Gianni, Walter Lugoboni, Fabio Marinangeli, Franco Massazza, Giuseppe Pinto, Carmine Varrassi, Giustino Pain Ther Original Research INTRODUCTION: Opioid-induced constipation (OIC) is the most common adverse effect of opioid therapy, but it is underdiagnosed and undertreated. Last year, a survey among Italian healthcare providers revealed important differences in the clinical management of OIC across physician specialties, the need of standardization of diagnosis and treatment, and the urgency of further education. Herein, we submitted an updated version of the survey to the same cohort of experts to evaluate potential progress. METHODS: The online survey included 15 questions about OIC. Responses were analyzed descriptively and aggregated by physician specialty. RESULTS: A total of 190 physicians completed the survey. Most respondents (65%) did not feel adequately educated about OIC despite general consensus regarding interest in the topic and acknowledgement of OIC impact on patients’ QoL and adherence to opioid therapy. Overall, 55–77% of physicians regularly evaluated intestinal function or OIC symptoms in patients receiving opioid therapy, with one-third of respondents implementing it in the past year. Even though the most common method for assessment was still patient diary, the use of specific scales underwent a small but significant increase compared to the previous year, with major implementation in the use of Rome IV criteria. As regards first-line treatment, most respondents (49%) preferred macrogol prophylaxis followed by macrogol plus another laxative. For second-line treatment, we revealed a growth in the prescription of peripherally acting mu-opioid receptor antagonists (PAMORAs), with 46% of all the respondents having increased their use during the past year. CONCLUSIONS: Despite some limitations, our study demonstrated a slow but important step closer to standardization of diagnosis and treatment of OIC. Further educational and training efforts should be put in place to favor best evidence-based clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40122-022-00354-4. Springer Healthcare 2022-02-05 2022-06 /pmc/articles/PMC9098716/ /pubmed/35122615 http://dx.doi.org/10.1007/s40122-022-00354-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Alvaro, Domenico
Coluzzi, Flaminia
Gianni, Walter
Lugoboni, Fabio
Marinangeli, Franco
Massazza, Giuseppe
Pinto, Carmine
Varrassi, Giustino
Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title_full Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title_fullStr Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title_full_unstemmed Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title_short Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
title_sort opioid-induced constipation in real-world practice: a physician survey, 1 year later
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098716/
https://www.ncbi.nlm.nih.gov/pubmed/35122615
http://dx.doi.org/10.1007/s40122-022-00354-4
work_keys_str_mv AT alvarodomenico opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT coluzziflaminia opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT gianniwalter opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT lugobonifabio opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT marinangelifranco opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT massazzagiuseppe opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT pintocarmine opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater
AT varrassigiustino opioidinducedconstipationinrealworldpracticeaphysiciansurvey1yearlater